Caspofungin versus liposomal amphotericin B for empirical therapy [1] (multiple letters)

Dimitrios P. Kontoyiannis; Russell E. Lewis; Pierre Tattevin; Benoît Bareau; Christophe Camus; Francisco M. Marty; Colleen M. Lowry; Markus Schneemann; Alexander Imhof; Patrick J. Danaher; Brian L. Jones; Lorna A. McLintock; Thomas J. Walsh; Gerald R. Donowitz; Ben E. DePauw

doi:10.1056/NEJM200501273520417

Caspofungin versus liposomal amphotericin B for empirical therapy [1] (multiple letters)

Dimitrios P. Kontoyiannis
, Russell E. Lewis
, Pierre Tattevin
, Benoît Bareau
, Christophe Camus
, Francisco M. Marty
, Colleen M. Lowry
, Markus Schneemann
, Alexander Imhof
, Patrick J. Danaher
, Brian L. Jones
, Lorna A. McLintock
, Thomas J. Walsh
, Gerald R. Donowitz
, Ben E. DePauw

Division of Infectious Diseases

Producción científica: Letter › revisión exhaustiva

16 Citas (Scopus)

Idioma original	English (US)
Páginas (desde-hasta)	410-414
Número de páginas	5
Publicación	New England Journal of Medicine
Volumen	352
N.º	4
DOI	https://doi.org/10.1056/NEJM200501273520417
Estado	Published - ene 27 2005

ASJC Scopus subject areas

General Medicine

Acceder al documento

10.1056/NEJM200501273520417

Otros archivos y enlaces

Citar esto

Kontoyiannis, D. P., Lewis, R. E., Tattevin, P., Bareau, B., Camus, C., Marty, F. M., Lowry, C. M., Schneemann, M., Imhof, A., Danaher, P. J., Jones, B. L., McLintock, L. A., Walsh, T. J., Donowitz, G. R., & DePauw, B. E. (2005). Caspofungin versus liposomal amphotericin B for empirical therapy [1] (multiple letters). New England Journal of Medicine, 352(4), 410-414. https://doi.org/10.1056/NEJM200501273520417

Kontoyiannis, DP, Lewis, RE, Tattevin, P, Bareau, B, Camus, C, Marty, FM, Lowry, CM, Schneemann, M, Imhof, A, Danaher, PJ, Jones, BL, McLintock, LA, Walsh, TJ, Donowitz, GR & DePauw, BE 2005, 'Caspofungin versus liposomal amphotericin B for empirical therapy [1] (multiple letters)', New England Journal of Medicine, vol. 352, n.º 4, pp. 410-414. https://doi.org/10.1056/NEJM200501273520417

@article{9b154c993e3148f98b50188395dc9d60,

title = "Caspofungin versus liposomal amphotericin B for empirical therapy [1] (multiple letters)",

author = "Kontoyiannis, \{Dimitrios P.\} and Lewis, \{Russell E.\} and Pierre Tattevin and Beno{\^i}t Bareau and Christophe Camus and Marty, \{Francisco M.\} and Lowry, \{Colleen M.\} and Markus Schneemann and Alexander Imhof and Danaher, \{Patrick J.\} and Jones, \{Brian L.\} and McLintock, \{Lorna A.\} and Walsh, \{Thomas J.\} and Donowitz, \{Gerald R.\} and DePauw, \{Ben E.\}",

year = "2005",

month = jan,

day = "27",

doi = "10.1056/NEJM200501273520417",

language = "English (US)",

volume = "352",

pages = "410--414",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "4",

}

TY - JOUR

T1 - Caspofungin versus liposomal amphotericin B for empirical therapy [1] (multiple letters)

AU - Kontoyiannis, Dimitrios P.

AU - Lewis, Russell E.

AU - Tattevin, Pierre

AU - Bareau, Benoît

AU - Camus, Christophe

AU - Marty, Francisco M.

AU - Lowry, Colleen M.

AU - Schneemann, Markus

AU - Imhof, Alexander

AU - Danaher, Patrick J.

AU - Jones, Brian L.

AU - McLintock, Lorna A.

AU - Walsh, Thomas J.

AU - Donowitz, Gerald R.

AU - DePauw, Ben E.

PY - 2005/1/27

Y1 - 2005/1/27

UR - https://www.scopus.com/pages/publications/13744251323

UR - https://www.scopus.com/pages/publications/13744251323#tab=citedBy

U2 - 10.1056/NEJM200501273520417

DO - 10.1056/NEJM200501273520417

M3 - Letter

C2 - 15675090

AN - SCOPUS:13744251323

SN - 0028-4793

VL - 352

SP - 410

EP - 414

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 4

ER -